Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases.

AIM To investigate the clinicopathological features of intraductal neoplasm of the intrahepatic bile duct (INihB). METHODS Clinicopathological features of 24 cases of INihB, which were previously diagnosed as biliary papillomatosis or intraductal growth of intrahepatic biliary neoplasm, were reviewed. Mucin immunohistochemistry was performed for mucin (MUC)1, MUC2, MUC5AC and MUC6. Ki-67, P53 and β-catenin immunoreactivity were also examined. We categorized each tumor as adenoma (low grade), borderline (intermediate grade), and malignant (carcinoma in situ, high grade including tumors with microinvasion). RESULTS Among 24 cases of INihB, we identified 24 tumors. Twenty of 24 tumors (83%) were composed of a papillary structure; the same feature observed in intraductal papillary neoplasm of the bile duct (IPNB). In contrast, the remaining four tumors (17%) showed both tubular and papillary structures. In three of the four tumors (75%), macroscopic mucin secretion was limited but microscopic intracellular mucin was evident. Histologically, 16 tumors (67%) were malignant, three (12%) were borderline, and five (21%) were adenoma. Microinvasion was found in four cases (17%). Immunohistochemical analysis revealed that MUC1 was not expressed in the borderline/adenoma group but was expressed only in malignant lesions (P = 0.0095). Ki-67 labeling index (LI) was significantly higher in the malignant group than in the borderline/adenoma group (22.2 ± 15.5 vs 7.5 ± 6.3, P < 0.01). In the 16 malignant cases, expression of MUC5AC showed borderline significant association with high Ki-67 LI (P = 0.0622). Nuclear expression of β-catenin was observed in two (8%) of the 24 tumors, and these two tumors also showed MUC1 expression. P53 was negative in all tumors. CONCLUSION Some cases of INihB have a tubular structure, and are subcategorized as IPNB with tubular structure. MUC1 expression in INihB correlates positively with degree of malignancy.

[1]  Jing Xu,et al.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. , 2010, World journal of hepatology.

[2]  Yasunori Sato,et al.  Intraductal tubular neoplasm of the common bile duct , 2010, Pathology international.

[3]  M. Ocker,et al.  Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. , 2009, International journal of oncology.

[4]  K. Jang,et al.  Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. , 2009, Oncology reports.

[5]  Masakazu Yamamoto,et al.  Intraductal Tubulopapillary Neoplasms of the Pancreas Distinct From Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms , 2009, The American journal of surgical pathology.

[6]  K. Jang,et al.  Intraductal tubular carcinoma of the pancreas: a case report with the imaging findings. , 2008 .

[7]  Y. Nimura,et al.  Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[8]  Y. Nakanuma,et al.  Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.

[9]  Y. Nakanuma,et al.  Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct , 2006, Modern Pathology.

[10]  N. Hiraoka,et al.  Intraductal tubular carcinoma in an adenoma of the main pancreatic duct of the pancreas head , 2006, Journal of Gastroenterology.

[11]  P. Singh,et al.  RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[12]  Y. Jan,et al.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis. , 2006, Journal of hepatology.

[13]  R. Hruban,et al.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.

[14]  H. Iwasaki,et al.  Intraductal Tubular Adenoma of the Pancreas, Pyloric Gland Type: A Clinicopathologic and Immunohistochemical Study of 6 Cases , 2005, The American journal of surgical pathology.

[15]  S. Batra,et al.  Pathologic Features of Mucin-producing Bile Duct Tumors: Two Histopathologic Categories as Counterparts of Pancreatic Intraductal Papillary-mucinous Neoplasms , 2004, The American journal of surgical pathology.

[16]  E. Furth,et al.  Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. , 2003, Human pathology.

[17]  T. Motoyama,et al.  Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas , 2002, Virchows Archiv.

[18]  K. Sugimachi,et al.  Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma , 2001, Modern Pathology.

[19]  S. Myung,et al.  Mucin-Hypersecreting Bile Duct Tumor Characterized by a Striking Homology with an Intraductal Papillary Mucinous Tumor (IPMT) of the Pancreas , 2000, Endoscopy.

[20]  M. Nagino,et al.  Treatment Strategy for Mucin-producing Intrahepatic Cholangiocarcinoma: Value of Percutaneous Transhepatic Biliary Drainage and Cholangioscopy , 1999, World Journal of Surgery.

[21]  S. Isaji,et al.  Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. , 1999, Journal of hepato-biliary-pancreatic surgery.

[22]  T. Okai,et al.  Mucin-producing biliary papillomatosis associated with gastrobiliary fistula , 1999, Journal of Gastroenterology.

[23]  R. Hruban,et al.  Pyloric gland adenoma of the main pancreatic duct. , 1999, The American journal of surgical pathology.

[24]  B. Gumbiner.  Signal transduction of beta-catenin. , 1995, Current opinion in cell biology.

[25]  K. Ishak,et al.  Hepatobiliary Cystadenoma and Cystadenocarcinoma: A Light Microscopic and Immunohistochemical Study of 70 Patients , 1994, The American journal of surgical pathology.

[26]  M. Kojiro,et al.  Intrahepatic and extrahepatic biliary papillomatosis. , 1993, Archives of pathology & laboratory medicine.

[27]  H. Shahinian,et al.  Tubular adenoma of the main pancreatic duct. , 1992, Archives of surgery.

[28]  Yong Il Kim,et al.  Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection , 1989, Cancer.

[29]  K. Ohtomo,et al.  Mucin-hypersecreting intrahepatic biliary neoplasms. , 1988, Radiology.

[30]  B. Helpap.  Malignant papillomatosis of the intrahepatic bile ducts. , 1977, Acta hepato-gastroenterologica.

[31]  Y. I. Kim,et al.  Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver , 2000, Abdominal Imaging.